MedicareYourself

Medicare Broker for Arthritis Sufferers — Coverage That Doesn't Make You Negotiate Twice

Medicare broker for arthritis sufferers

A Medicare broker for arthritis sufferers does one thing most online tools can't: match your exact medications, specialists, and joint care needs to the plan that actually covers them. Some mornings your joints decide the agenda before your brain does. Buttons, stairs, jar lids. You're already negotiating with your body. Your insurance shouldn't be another fight.

I'm Anthony Orner, a licensed Medicare broker. I compare every plan available in your area against your prescriptions and providers, at no cost to you.

Call for Free Advice — 855-559-1700

How Medicare covers biologics, DMARDs, and joint replacements

Medicare splits arthritis drug coverage in a way that catches people off guard. Infused biologics like Remicade go through Part B at your doctor's office. Self-injected biologics like Humira or Enbrel go through Part D.

DMARDs like methotrexate are Part D. Joint replacements are covered under Part A as inpatient procedures. Each "part" has different cost-sharing, and the wrong plan choice can mean hundreds or thousands in unexpected bills.

Why drug formularies matter more than you think with arthritis

Every Part D plan has its own formulary. One plan might put your biologic on Tier 3. Another puts it on Tier 5 with a $1,800 monthly copay. People who've been on commercial insurance or Medicaid are blindsided by this when they switch to Medicare.

The drug that finally works for your RA or PsA might technically be "covered" but priced so high it's functionally not. I check every formulary in your ZIP code so you don't find out the hard way.

Supplement vs. Advantage plans for chronic joint conditions

  • Original Medicare + Medigap + Part D: See any Medicare-accepting doctor. No referrals needed for rheumatologists. Predictable costs. You'll pay a separate Part D premium, so formulary research is essential.
  • Medicare Advantage (Part C): Often lower monthly premiums. May require prior authorizations for biologics and specialist visits. Network restrictions can limit your choice of rheumatologist.

For someone managing active RA or PsA with biologics, provider flexibility and drug coverage usually outweigh a lower premium. But the right answer depends on your specific situation.

Prior authorizations and step therapy for arthritis drugs

Many Medicare Advantage and Part D plans require step therapy. That means they'll want you to try cheaper drugs first before they approve the one your rheumatologist actually prescribed. If you've already failed methotrexate and two other DMARDs, you shouldn't have to prove it again to a new plan.

I look at which plans have the fewest authorization hurdles for your current treatment. Less red tape, fewer gaps in care.

The real cost numbers you need to know in 2026

  • Part B premium (2026): $202.90/month
  • Part B deductible: $283/year
  • Part A deductible: $1,676 per benefit period
  • Part D/Advantage Open Enrollment: October 15 through December 7
  • Medigap Open Enrollment: 6 months starting when you're 65+ and enrolled in Part B

For arthritis patients considering Medigap, that 6-month open enrollment window matters. Carriers must accept you regardless of your RA or PsA diagnosis during that period. Miss it, and underwriting can price you out or deny you.

Get a free plan review built around what your body actually needs

Bring me your medication list, your rheumatologist's name, and your ZIP code. I'll show you every plan option, what each one will cost you for the year, and which ones cover your drugs without forcing you through step therapy hoops.

No charge. No obligation. I get paid by the carriers, not by you. Same plans, same prices, better guidance.

Call 855-559-1700 for a free arthritis-focused plan comparison

Or request a callback at a time that works for you.

Get a Free Quote

Frequently Asked Questions

Related resources